Aytu BioPharma Inc (LTS:0A8M)
$ 1.59 -0.01 (-0.62%) Market Cap: 9.90 Mil Enterprise Value: 6.35 Mil PE Ratio: 0 PB Ratio: 0.33 GF Score: 40/100

Q3 2023 Aytu Biopharma Inc Earnings Call Transcript

May 11, 2023 / 08:30PM GMT
Release Date Price: $2.17 (+6.90%)
Operator

Greetings. Welcome to the Aytu BioPharma fiscal 2023 Q3 results conference call. (Operator Instructions) Please note this conference is being recorded.

I'll now turn the conference over to your host, Roger Weiss. You may begin.

Roger Weiss
Lytham Partners, LLC - IR

Good afternoon, everyone, and thank you for joining us for the Aytu BioPharma's third-quarter fiscal year 2023 financial results conference call for the period ending March 31, 2023. Joining us on today's call is Aytu's CEO, Josh Disbrow; and the company's Chief Financial Officer, Mark Oki. At the conclusion of today's prepared remarks, we will open the call for a question-and-answer session.

I'd like to remind everyone that today's call is being recorded. A replay of today's call will be available by using the telephone numbers and conference ID provided in the earnings press release issued earlier today.

Finally, I'd like to call to your attention to the customary Safe Harbor disclosure regarding forward-looking information. The conference call today will contain

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot